title: Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson's disease.
authors.affiliation: Parkinson-Klinik Wolfach, University of Freiburg, Wolfach, Germany. w.jost@parkinson-klinik.de.
authors.forename: W H
authors.initials: WH
authors.lastname: Jost
authors.forename: M
authors.initials: M
authors.lastname: Friede
authors.forename: J
authors.initials: J
authors.lastname: Schnitker
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000627:therapeutic use*
chemical_list: D000978:Antiparkinson Agents; D007189:Indans; D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline